Tissue-specific growth suppression and c
โ
G W Xu; Z T Sun; K Forrester; X W Wang; J Coursen; C C Harris
๐
Article
๐
1996
๐
John Wiley and Sons
๐
English
โ 646 KB
HCC patients are generally resistant to chemotherapy, Selective expression of cytotoxic gene products in tuwhich, in some cases, may be the result of a loss of function mor cells is one of the goals of gene therapy for treating mutation in the p53 gene. cancer. We are developing such a strategy for